Cancer Research · 2007 · 216 citations · 42 references
Life SciencesBiochemistryOncologyCarcinogenesisMolecular OncologyNeoplasiaCellular Responses To HypoxiaMitochondrial SignalingMitochondrial Stress ResponsesOxidative StressReactive Oxygen SpeciesRedox SignalingCellular Hypoxia SignalingHypoxia-induced SignalingHypoxia-inducible Factor ActivationHypoxia-inducible Factor SignalingMitochondrial Reactive Oxygen Species SignalingNf-κb SignalingNuclear Factor Kappa B ActivationProtein Tyrosine Phosphorylation
Hypoxia is a prominent feature of solid tumor development and is known to stimulate mitochondrial ROS (mROS), which, in turn, can activate hypoxia-inducible transcription factor-1alpha and nuclear factor-kappaB (NF-kappaB). Because NF-kappaB plays a central role in carcinogenesis, we examined the mechanism of mROS-mediated NF-kappaB activation and the fate of cancer cells during hypoxia after mitochondrial reduced glutathione (mGSH) depletion. Hypoxia generated mROS in hepatoma (HepG2, H35), neuroblastoma (SH-SY5Y), and colon carcinoma (DLD-1) cells, leading to hypoxia-inducible transcription factor-1alpha-dependent gene expression and c-Src activation that was prevented in cells expressing a redox-insensitive c-Src mutant (C487A). c-Src stimulation activated NF-kappaB without IkappaB-alpha degradation due to IkappaB-alpha tyrosine phosphorylation that was inhibited by rotenone/TTFA or c-Src antagonism. The c-Src-NF-kappaB signaling contributed to the survival of cells during hypoxia as c-Src inhibition or p65 down-regulation by small interfering RNA-sensitized HepG2 cells to hypoxia-induced cell death. Moreover, selective mGSH depletion resulted in an accelerated and enhanced mROS generation by hypoxia that killed SH-SY5Y and DLD-1 cells without disabling the c-Src-NF-kappaB pathway. Thus, although mROS promote cell survival by NF-kappaB activation via c-Src, mROS overgeneration may be exploited to sensitize cancer cells to hypoxia.
42
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Thomas G. Graeber, Cynthia Osmanian, Tyler Jacks et al. · Nature · 1996 · 2.3K citations
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Patrick A. Baeuerle, David Baltimore · Science · 1988 · 2.2K citations
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Mary Selak, Sean M. Armour, Elaine D. MacKenzie et al. · Cancer Cell · 2005 · 2.1K citations · Full text
Medicine, Cancer Biology, Oncology +14